519 results on '"Lutz, Patrick"'
Search Results
52. Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A
53. Results on Martin’s Conjecture
54. Laparoscopic Partial Splenectomy: Indications and results of a multicenter retrospective study
55. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
56. Involvement of MET/TWIST/APC Combination or the Potential Role of Ossification Factors in Pediatric High-Grade Osteosarcoma Oncogenesis
57. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway
58. Corrigenda to “Incompleteness and jump hierarchies”
59. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience
60. Thymus and mediastinal node involvement in childhood langerhans cell histiocytosis: Long-term follow-up from the French national cohort
61. Tolerance and efficacy of preventive gastrostomy feeding in pediatric oncology
62. Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE)
63. Childhood hodgkinʼs lymphoma, non-hodgkinʼs lymphoma and factors related to the immune system: The escale study (SFCE)
64. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951
65. Metabolomic pattern of childhood neuroblastoma obtained by 1H-high-resolution magic angle spinning (HRMAS) NMR spectroscopy
66. Incompleteness and jump hierarchies
67. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
68. Rituximab in the Management of Chronic Immune Thrombocytopenic Purpura: What Is Its Place?
69. Is Pegfilgrastim Safe and Effective in Congenital Neutropenia? An Analysis of the French Severe Chronic Neutropenia Registry
70. Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease
71. Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas
72. Prognostic Significance of Allelic Imbalance at the c-kit Gene Locus and c-kit Overexpression by Immunohistochemistry in Pediatric Osteosarcomas
73. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951
74. Use of Pulsed-Field Gel Electrophoresis for a Pseudoepidemic of Clostridium difficile Infections in a Pediatric Oncology and Hematology Department
75. Lymphocyte data in Epstein–Barr-virus induced post-transplant lymphoproliferative disorder treated by rituximab
76. Aspergillus Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
77. Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children
78. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
79. In a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ
80. A de novo heterozygous deletion of 42 base-pairs in the noggin gene of a fibrodysplasia ossificans progressiva patient
81. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas
82. Genotype/phenotype correlations of childhood‐onset congenital sideroblastic anaemia in a European cohort
83. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study
84. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Societe Francaise de Greffe de Moelle study
85. Comparison of Escherichia coli–asparaginase withErwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children's Leukemia Group phase 3 trial
86. Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology
87. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia
88. Second research workshop on Archetype analysis in sustainability research
89. Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: Final results of the EORTC-CLG randomized phase III trial 58951
90. Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
91. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: Results of the EORTC CLG 58881 and 58951 trials
92. Paternal Treatment For Sterility And Neonatal Neuroblastoma
93. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study
94. Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials
95. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
96. Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.
97. Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study
98. Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group
99. Late Effects in Survivors of Infantile Acute Leukemia Are Less Severe Than Expected: A Study of the L.E.a Program
100. Metabolic Syndrome in Long-Term Survivors of Childhood Acute Leukemia Treated without Hematopoietic Stem Cell Transplantation: An L.E.Α. Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.